Posted on 03/06/2022 6:10:55 PM PST by simpson96
Investors who take an interest in Clover Health Investments, Corp. (NASDAQ:CLOV) should definitely note that the Independent Director, Chelsea Clinton, recently paid US$2.53 per share to buy US$253k worth of the stock. However, it only increased shareholding by a small percentage, and it wasn't a huge purchase by absolute value, either.
View our latest analysis for Clover Health Investments
Clover Health Investments Insider Transactions Over The Last Year The insider Chamath Palihapitiya made the biggest insider purchase in the last 12 months. That single transaction was for US$10.0m worth of shares at a price of US$5.75 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$2.20). Their view may have changed since then, but at least it shows they felt optimistic at the time. We always take careful note of the price insiders pay when purchasing shares. Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.
(Excerpt) Read more at simplywall.st ...
Yet she just can’t bring herself to care about money!
What’s about to happen to Medicare ?
If the buy is for $5.75 and the sell price is $2.20 what keeps the broker from pocketing the difference if the order is completed?
She learned investing from her mom.
Now would be a good time to invest in cattle futures too.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.